Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Statement regarding Indivior Chair

15th Jun 2020 07:00

RNS Number : 8893P
Indivior PLC
15 June 2020
 

June 15, 2020

 

Indivior PLC - Board Announcement

 

Chair to take a leave of absence

 

Indivior PLC announces that the Chair, Howard Pien, is to take a leave of absence for medical reasons. Daniel Tassé will act as Interim Chair in Mr Pien's absence.

 

Daniel joined the Board in 2014 and was appointed Senior Independent Director in 2016 (bio). He is a member of the Audit and Remuneration Committees and is also a member of the Special Committee.

 

In considering Mr Tassé's appointment as Interim Chair, the Board took into account his deep understanding of the pharmaceuticals sector and Indivior's business and his confirmation that he is able to devote sufficient time to the role.

 

Investor Contact:

Jason Thompson, IndiviorVice President, Investor Relations+1 804-402-7123[email protected]

Media Contacts:

UKTulchan Communications+44 207-353-4200

US[email protected]+1 804-594-0836

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOADGGDLXBBDGGS

Related Shares:

Indivior
FTSE 100 Latest
Value8,809.74
Change53.53